Incannex Healthcare has said its PSX-001 oral synthetic psilocybin programme [...]

Veristat has agreed to acquire Certara’s regulatory and medical writing [...]

The National Institute for Health and Care Excellence (NICE) has [...]

BridgeBio Pharma has submitted a New Drug Application (NDA) to [...]

Medtronic has announced a series of US regulatory and reimbursement [...]

Spore.Bio has appointed Michael Miller as vp of scientific and [...]

AstraZeneca has reported positive interim results from the Phase 3 [...]

Amber Implants has received FDA 510(k) clearance for its VCFix [...]

Axplora has announced a €6.5 million investment at its Vizag [...]

As the FDA accelerates its use of generative AI in [...]